# A Study of Children With Refractory or Relapsed ALL

> **NCT00187083** · PHASE3 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 40 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** Topotecan, dexamethasone, vincristine
- **DRUG:** E. coli Asparaginase, PEG-L-asparaginase
- **DRUG:** erwinia asparaginase
- **DRUG:** fludarabine, methotrexate, mercaptopurine
- **DRUG:** idarubicin, etoposide, cytarbine, teniposide
- **PROCEDURE:** chemotherapy, intrathecal chemotherapy, steroid therapy

## Key facts

- **NCT ID:** NCT00187083
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-02
- **Primary completion:** 2003-12
- **Final completion:** 2003-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2008-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00187083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00187083, "A Study of Children With Refractory or Relapsed ALL". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00187083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*